This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 01/23/2020
Location: Silver Spring, MD
Subject: Reagan-Udall Foundation Board of Directors Meeting: Introductions
FDA Participant/Group: DENISE HINTON; JACQUELINE CORRIGAN CURAY; ROBIN MCKINNON; DIANE MALONEY;
Non FDA Participant/Group: Several members of the Reagan-Udall Foundation Board

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

No Significant Event

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/22/2020
Location: Washington, DC
Subject: Pharmaceutical Research and Manufacturers of America (PhRMA) Global Regulatory Leadership Dinner
FDA Participant/Group: N/A
Non FDA Participant/Group: Widely attended gathering

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/22/2020
Location: Miami, FL
Subject: World Stem Cell Summit; Keynote Address: Stem Cell Therapy Product Development - What’s on the Horizon for 2020
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from government, industry and academia

Event Date: 01/22/2020
Location: Miami, FL
Subject: World Stem Cell Summit; Speaker: Making Use of the Regenerative Medicine Regulatory Toolkit
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from government, industry and academia

Event Date: 01/22/2020
Location: Miami, FL
Subject: World Stem Cell Summit; Speaker: Encouraging Legitimate Research and Compliance – a Q&A with the Regulator
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from government, industry and academia

Event Date: 01/22/2020
Location: Miami, FL
Subject: World Stem Cell Summit; Panel Discussion: Recent Advances on Regenerative Medicine Advanced Therapy (RMAT) and Tissue Rapid Inquiry Program (TRIP)
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from government, industry and academia

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 01/21/2020
Location: Rockville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: AMBER MCCOIG; TIMOTHY SCHELL; SIOBHAN DELANCEY; JANICE STEINSCHNEIDER; WILLIAM FLYNN; NICOLE PEPPERL;
Non FDA Participant/Group: Alliance for Pharmacy Compounding representatives

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event